122 related articles for article (PubMed ID: 38181892)
1. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract][Full Text] [Related]
2. HERC4 exerts an anti-tumor role through destabilizing the oncoprotein Smo.
Sun X; Sun B; Cui M; Zhou Z
Biochem Biophys Res Commun; 2019 Jun; 513(4):1013-1018. PubMed ID: 31010679
[TBL] [Abstract][Full Text] [Related]
3. SAV1, regulated by HERC4, inhibits the proliferation, migration, and invasion of hepatocellular carcinoma.
Huang F; Tang X; Sun T; Wang G; Ru Q; Zheng Y
Transl Cancer Res; 2021 Jan; 10(1):349-360. PubMed ID: 35116265
[TBL] [Abstract][Full Text] [Related]
4. HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.
Zheng Y; Li J; Pan C; Zhou G; Zhuge L; Jin L; Fang P
DNA Cell Biol; 2017 Jun; 36(6):490-500. PubMed ID: 28430527
[TBL] [Abstract][Full Text] [Related]
5. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
Xu Y; Ji K; Wu M; Hao B; Yao KT; Xu Y
Protein Cell; 2019 Aug; 10(8):595-605. PubMed ID: 30710319
[TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of HERC4 in breast cancer.
Zhou H; Shi R; Wei M; Zheng WL; Zhou JY; Ma WL
Cancer Cell Int; 2013 Nov; 13(1):113. PubMed ID: 24225229
[TBL] [Abstract][Full Text] [Related]
7. [Expression of E3 ligase HERC4 in breast cancer and its clinical implications].
Zhou H; Shi R; Chen Y; Zeng W; Liang S; Zheng W; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1110-4. PubMed ID: 25176076
[TBL] [Abstract][Full Text] [Related]
8. [RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells].
Wei M; Zhang YL; Chen L; Cai CX; Wang HD
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):232-237. PubMed ID: 28219869
[TBL] [Abstract][Full Text] [Related]
9. E3 ligase Herc4 regulates Hedgehog signalling through promoting Smoothened degradation.
Jiang W; Yao X; Shan Z; Li W; Gao Y; Zhang Q
J Mol Cell Biol; 2019 Sep; 11(9):791-803. PubMed ID: 30925584
[TBL] [Abstract][Full Text] [Related]
10. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
11. Smoothened antagonists reverse taxane resistance in ovarian cancer.
Steg AD; Katre AA; Bevis KS; Ziebarth A; Dobbin ZC; Shah MM; Alvarez RD; Landen CN
Mol Cancer Ther; 2012 Jul; 11(7):1587-97. PubMed ID: 22553355
[TBL] [Abstract][Full Text] [Related]
12. Smoothened as a new therapeutic target for human osteosarcoma.
Hirotsu M; Setoguchi T; Sasaki H; Matsunoshita Y; Gao H; Nagao H; Kunigou O; Komiya S
Mol Cancer; 2010 Jan; 9():5. PubMed ID: 20067614
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
14. B13, a well-tolerated inhibitor of hedgehog pathway, exhibited potent anti-tumor effects against colorectal carcinoma in vitro and in vivo.
Wu H; Zhang L; Chen B; Ou B; Xu J; Tian N; Yang D; Ai Y; Chen Q; Quan D; Zhang T; Lv L; Tian Y; Zhang J; Wu S
Bioorg Chem; 2023 Jun; 135():106488. PubMed ID: 36989734
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SMYD3 in Ovarian Cancer is Associated with Ovarian Cancer Proliferation and Apoptosis via Methylating H3K4 and H4K20.
Jiang Y; Lyu T; Che X; Jia N; Li Q; Feng W
J Cancer; 2019; 10(17):4072-4084. PubMed ID: 31417652
[No Abstract] [Full Text] [Related]
16. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
Weng H; Feng X; Lan Y; Zheng Z
J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426
[TBL] [Abstract][Full Text] [Related]
17. Syntaxin 6 Enhances the Progression of Epithelial Ovarian Cancer by Promoting Cancer Cell Proliferation.
Zhang W; Lv Q; Lu D; Chen F
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2003-2010. PubMed ID: 37378930
[TBL] [Abstract][Full Text] [Related]
18. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract][Full Text] [Related]
19. miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in Hedgehog pathway.
Ma J; Zhou C; Chen X
Cancer Cell Int; 2021 Jan; 21(1):64. PubMed ID: 33472614
[TBL] [Abstract][Full Text] [Related]
20. Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors.
Song X; Yan L; Lu C; Zhang C; Zhu F; Yang J; Jing H; Zhang Y; Qiao J; Guo H
Oncol Lett; 2018 Apr; 15(4):5569-5576. PubMed ID: 29552194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
